Leprosy in a Mexican immigrant.
A new diagnosis of borderline lepromatous leprosy was established in a man who had immigrated to Kentucky from Mexico. He was placed on a World Health Organization treatment regimen consisting of dapsone, clofazimine, and rifampin. The biology of leprosy, its diagnosis, treatment, and worldwide impact are reviewed. Because of the potential for highly mobile populations to export endemic diseases, Kentucky physicians must expand their lists of differential diagnoses.
Baker
Brian
B
University of Kentucky Medical Center, USA.
Evans
Martin
M
DeCastro
Fernando
F
Schosser
Robert
R
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D004641:Emigration and Immigration; D005500:Follow-Up Studies; D006630:Hispanic or Latino; D006801:Humans; D007629:Kentucky; D007917:Leprostatic Agents / Q000008:administration & dosage; D015439:Leprosy, Borderline / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007917:Leprostatic Agents